Metabolic syndrome and symptom burden in allogeneic hematopoietic stem cell transplantation survivors
Recipients of allogeneic HCT have a high incidence of metabolic syndrome, symptom burden, and impaired physical function.
Authors
- Christopher Wichman (ORCID: https://orcid.org/0000-0003-4642-1591)
- Jonathan Q. Trinh (ORCID: https://orcid.org/0000-0001-7830-1792)
- Michael Haddadin (ORCID: https://orcid.org/0009-0000-9186-5648)
- Lori Maness-Harris
- Vijaya Raj Bhatt (ORCID: https://orcid.org/0000-0003-2513-0533)
- Jonathan Nilles
- Krishna Gundabolu (ORCID: https://orcid.org/0000-0003-4206-7468)
- Moataz Ellithi (ORCID: https://orcid.org/0000-0002-6261-4898)
Institutions
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Future Oncology
- Published
- 2024-11-24
- DOI
- https://doi.org/10.1080/14796694.2024.2431476
- Citations
- 2
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.91